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Background. Intraplacental choriocarcinoma is a rare but highly malignant trophoblastic neoplasm. When found near term the
risk of maternal metastasis is high because of the late diagnosis. Case. We describe a case of an intraplacental choriocarcinoma
diagnosed postpartum after a near-term delivery of a severely anemic infant. A fetomaternal hemorrhage resulted in a hemoglobin
concentration in the infant of only 2,1g/dL. Neither mother nor child showed signs of metastatic disease. The macroscopic
examination showed a hydropic placenta weighing more than 1 kilogram. Microscopy showed an intraplacental choriocarcinoma
3cm in diameter. The tumor had inﬁltrated the maternal basal plate. Conclusion. Fetomaternal bleeding is a rare form of
presentation of choriocarcinoma but its presence should always warrant detailed examination of placenta, mother, and infant.
1.Introduction
Gestational trophoblastic disease (GTD) covers a spectrum
of diseases from benign trophoblastic lesions over the pre-
malignant abnormal conceptions, the hydatidiform moles,
either partial or complete, to the more rare malignant
forms, the invasive mole, the placental site and epithelioid
trophoblastic tumors and choriocarcinoma [1].
Choriocarcinoma is a rare but highly malignant tumor,
the most aggressive form of gestational trophoblastic disease
[2] and intraplacental choriocarcinoma is a rare variant
accounting for no more than approximately 0.04% of
gestational trophoblastic disease [3]. The risk of gestational
trophoblastic disease is increased in older and multiparous
women and in very young women [4].
Choriocarcinoma following a live birth is reported to
have an incidence of 1 in 50000 births and to be associated
with a poor prognosis, as a delay in diagnosis increases
the risk of widespread dissemination, both maternal and
fetal [5–7]. Massive feto-maternal hemorrhage can cause
fetal distress and death at term and the possibility of
intraplacental choriocarcinoma should always be considered
in these cases [5].
We describe a case of an intraplacental choriocarcinoma
causing massive feto-maternal bleeding in a near term
pregnancy with signs of fetal distress.
2.CaseReport
The mother was a 47-year-old woman, para 7, originally
from Somalia. The father was 71 years old. The mother
p r e s e n t e da t3 5+6w e e k so fg e s t a t i o n a la g ea f t e r3d a y s
of decreased fetal movements. Cardiotocography (CTG)
was severely pathologic, showing a preterminal pattern.
Emergency caesarean section was performed.
The antenatal course had been uneventful up until the
last few weeks before delivery when the mother had started
to complain about fatigue and palpitations. Four days
before delivery the mother had fainted and was examined2 Case Reports in Medicine
at the maternity ward. Her level of hemoglobin and the
electrocardiography (ECG) were normal, as was the CTG.
The newborn weighed 2800 gram and had Apgar scores
of 0 at 1 minute, 4 at 2 minutes and 7 at 5 minutes. At
birth a sample of umbilical arterial blood showed metabolic
acidosis. Blood glucose was normal.
At ﬁrst there were vital signs but soon the child turned
pale, weak and was without cardiac activity. Cardiopul-
monary resuscitation was initiated. The infant was found
to be severely anemic, the hemoglobin concentration in the
umbilical artery was 2.1g/dL. She was immediately treated
with blood transfusion.
Hereafter she was admitted to the neonatal intensive care
unit, where she was intubated, ventilated and treated with
nitrous oxide (NO) because of pulmonary hypertension.
Echocardiography showed severe distention of the right
side of the heart as well as a small apical ventricular septum
defect (VSD). Both ultrasound of the cerebrum and electro-
encephalogram (EEG) were normal. Because of neonatal
sepsis the infant was treated with a broad spectrum of
intravenous antibiotics.
The infant remained hospitalized for 1 month. The
serum levels of both alfa-foetoprotein and hCG were at all
times normal why no ultrasound, X-ray or CT scans were
performed in search for metastases. The infant showed no
signs of neurological damage. After discharge she was seen
regularly in the out-patient clinic with measurements of
serum levels of alfa-foetoprotein and hCG as well of mon-
itoring of her neurological development. The mother was
simultaneously examined because of the risk of widespread
disease. Chest X-ray revealed no metastatic lesion, neither
did ultrasound or CT scan of the abdomen.
The mother was referred to a regional oncology cen-
ter where serial serum concentrations of hCG and alfa-
foetoprotein were measured, for the ﬁrst month twice a
week and hereafter twice a month until 2 months after
normalization of the serum hCG level. From there on the
mother’s serum hCG will be measured every second month
until the level of serum hCG has been normal for 14
months. On the 17th day postpartum the hCG was 510iU/L
dropping to 16iU/L 36 days postpartum. Since there were
no signs of dissemination, the mother was not treated
with chemotherapy. Six months postpartum, both mother
and child are doing well, showing no signs of malignant
disease.
3.Pathological Findings
The placenta was large, pale and edematous. It weighed
1060g. On initial gross examination performed by a pathol-
ogist without knowledge of the clinical circumstances some
intraplacental hematomas were found. Histologically the
placenta was characterized by edematous immature villi
and a number of intraplacental hematomas (intervillous
thrombi). The fetal blood showed a signiﬁcant increase in
nucleated fetal red blood cells as a response to fetal anemia.
Before the ﬁnal report was issued the presence of severe feto-
maternal hemorrhage was communicated to the pathologist.
Figure 1: Intraplacental choriocarcinoma growing out from stem
villisharplydemarcatedfromsurroundingnormalvilli(H&E ×40).
Figure 2: Biphasic tumor tissue with neoplastic syncytiotro-
phoblast to the left and neoplastic cytotrophoblast to the right
(H&E ×200).
The placenta was reexamined and additional sections sub-
mitted. On gross reexamination, an indistinct 3cm poorly
demarcated soft hemorrhagic area was noted. Histologically
this area showed a biphasic tumor tissue growing out from
stem villi (Figure 1) and consisting of alternating areas of
highly atypical and pleomorphic syncytiotrophoblast and
cytotrophoblast (Figure 2). The tumor tissue showed an
irregularbutsharplydeﬁnedbordertowardsthesurrounding
nonneoplastic placental tissue (Figure 1). Small tumor satel-
lites were present near the main tumor mass and the tumor
had inﬁltrated the maternal basal plate and was present in
thedeepestaspectofthespecimen.Thetumorwasassociated
with signiﬁcant hemorrhage.
In this case, if the clinical information had not been
communicated to the pathologist, the intraplacental chori-
ocarcinoma would not have been found.Case Reports in Medicine 3
4. Discussion
Intraplacental choriocarcinoma is a very rare and aggressive
disease, seldom diagnosed at the time of delivery [7]. Earlier
studies have found that 4% of patients with persistent gesta-
tional trophoblastic disease are diagnosed with choriocarci-
nomafollowingtermpregnancy[7].Themajorityofpatients
with choriocarcinoma present weeks or months postpartum
with either vaginal bleeding, caused by vaginal or uterine
metastasesorsymptomsrelatedtometastasesinlungs,brain,
breast or liver [6]. 60% to 87% of patients with postterm
choriocarcinoma have been found to have metastases at the
time of diagnosis and the overall survival is around 86% in
patients with a postpartum choriocarcinoma [3, 7].
The prevalence of choriocarcinoma is low, but it is most
often seen in women less than 15 years or more than 45
y e a r so fa g e ,a sw e l la si nm u l t i p a r o u sw o m e n[ 4, 5, 8]. Both
advanced maternal age and multiparity was present in our
case of gestational choriocarcinoma.
Choriocarcinomas can be preceded by a complete mole,
a miscarriage or a normal pregnancy. Cases have been
described where choriocarcinoma is preceded by a partial
mole although this is more uncommon [2]. When preceeded
by a normal pregnancy the outcome is often intrauterine
death. Very often, intraplacental choriocarcinoma is associ-
atedwithmaternaldisseminated diseaseandmorerarelydis-
semination in the fetus as well [7]. When choriocarcinoma
is discovered with term pregnancy the risk of widespread
metastases is high. Although the condition is extremely
uncommon, it is potentially treatable. In the case of early
diagnosis and appropriate chemotherapy, prognosis is good
[7].
Indications for detailed examination or sometimes re-
examination of the placenta are evidence of maternal
metastatic disease or complications such as intrauterine fetal
death, stillbirth or as in our case fetomaternal hemorrhage
[9].
T h ec a u s e so ff e t o m a t e r n a lh e m o r r h a g ea r en u m e r o u s ,
including traumas to the uterus, placental chorangiomas
and procedures such as amniocentesis or external cephalic
version of the baby. In 1962 Benson et al. [10] were the ﬁrst
to describe a case of massive fetomaternal hemorrhage as
a complication of choriocarcinoma. Feto-maternal hemor-
rhage is a very rare form of presentation of choriocarcinoma
but whenever seen the question of malignancy should be
raised.
In our case the diagnosis of intraplacental chorio-
carcinoma was not found during the initial pathological
examination of the placenta, but the critical state of the
newborn because of signiﬁcant feto-maternal hemorrhage
ledtothere-examinationoftheplacentaandtothediscovery
of the malignancy.
Our case demonstrates that feto-maternal hemorrhage
should always be followed by detailed examination of the
placenta as well as serial serum-hCG monitoring of both
mother and child, in an attempt to diagnose early signs of
possible malignant dissemination.
The macroscopic diagnosis of placental tumor is often
diﬃcultbecauseofitsinnocuousgrossappearance,smallsize
andtheresemblancetobenignlesions,suchasinfarctionand
intraplacental hematoma [3, 9]. This case clearly illustrates
the importance of clinico-pathological correlation and we
presume that the prevalence of intraplacental choriocar-
cinoma is most probably notably higher than previously
reported.
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